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Abstract
Background: Elevated glucocorticoid production and reduced hypothalamic POMC mRNA can
cause obese phenotypes. Conversely, adrenalectomy can reverse obese phenotypes caused by the
absence of leptin, a model in which glucocorticoid production is elevated. Adrenalectomy also
increases hypothalamic POMC mRNA in leptin-deficient mice. However most forms of human
obesity do not appear to entail elevated plasma glucocorticoids. It is therefore not clear if reducing
glucocorticoid production would be useful to treat these forms of obesity. We hypothesized that
adrenalectomy would increase hypothalamic POMC mRNA and reverse obese phenotypes in
obesity due to a high-fat diet as it does in obesity due to leptin deficiency.
Results: Retired breeder male mice were placed on a high-fat diet or a low-fat diet for two weeks,
then adrenalectomized or sham-adrenalectomized. The high-fat diet increased body weight,
adiposity, and plasma leptin, led to impaired glucose tolerance, and slightly stimulated hypothalamic
proopiomelanocortin (POMC) expression. Adrenalectomy of mice on the high-fat diet significantly
reduced plasma corticosterone and strikingly increased both pituitary and hypothalamic POMC
mRNA, but failed to reduce body weight, adiposity or leptin, although slight improvements in
glucose tolerance and metabolic rate were observed.
Conclusion:  These data suggest that neither reduction of plasma glucocorticoid levels nor
elevation of hypothalamic POMC expression is effective to significantly reverse diet-induced
obesity.
Background
Chronically elevated cortisol levels caused by Cushing's
syndrome leads to central obesity [1] while the reduction
of cortisol caused by Addison's disease leads to decreased
body weight [2]. Obesity in several rodent models is also
associated with elevated corticosterone levels, and adrena-
lectomy reverses some of the phenotypes associated with
these forms of obesity [3–7]. Furthermore, elevated corti-
costerone production can cause a metabolic syndrome
[8]. These data suggest that reduction of glucocorticoid
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production might therefore constitute a plausible clinical
strategy to treat obesity. On the other hand, obesity in
humans does not generally entail elevated plasma cortisol
[9–13] and it is not clear how effective reduction of gluco-
corticoid production would be to reverse obesity if gluco-
corticoid production were otherwise normal.
Nevertheless, pharmacological antagonism of glucocorti-
coid (type II) receptor by mifepristone (RU486) was
reported to reverse high fat diet-induced obesity [14].
Since diet-induced obesity does not entail elevated gluco-
corticoid levels [15–17], this result suggests that reduction
of glucocorticoid levels would reverse obesity even when
glucocorticoid levels are not elevated.
Although the mechanisms through which adrenalectomy
acts to reverse obesity is not entirely clear, it is plausible
that the mechanisms entail enhanced hypothalamic
POMC production [6]. Hypothalamic POMC mRNA is
reduced in several forms of obesity [18–20]. Conversely,
reversal of obese phenotypes by adrenalectomy is associ-
ated with a restoration of hypothalamic POMC mRNA
tone in leptin-deficient ob/ob mice [6]. Furthermore, the
melanocortin agonist MTII (which mimics the key anti-
obesity product of POMC, alpha-MSH) reduces body
weight in diet-induced obesity [21]. On the other hand,
the effect of diet-induced obesity on hypothalamic POMC
mRNA is somewhat complex and may depend on the
genetic background [22,23], and duration of the diet
[24,25] or composition [23] of the diet. Furthermore, the
effect of adrenalectomy on hypothalamic POMC mRNA
may also depend genetic background [6,26,27]. Neverthe-
less, we hypothesized that if adrenalectomy enhanced
hypothalamic POMC mRNA in diet-induced obesity in
mice, as in leptin-deficient mice, adrenalectomy would
also reverse obese phenotypes in mice that became obese
due to a high-fat diet. In the present study, we observed
that adrenalectomy did indeed lead to a remarkable
enhancement of hypothalamic POMC mRNA tone in
mice made obese on a high-fat diet; surprisingly, however,
adrenalectomy did not reverse diet-induced obesity.
Results
Effects diet and adrenalectomy on body weight, adipose 
weight and caloric intake
Prior to adrenalectomy, mice on the high-fat diet gained
body weight about five-fold more rapidly than chow-fed
mice in the first seven days on the high-fat diet (chow fed
mice gained 0.68 ± 0.13 g compared to high-fat diet mice
which gained 5.1 ± 0.2 g over the first seven days on the
diet; p <0.05). At the end of the five week period, mice on
the high-fat diet, both sham-operated and adrenalect-
omized, exhibited a significant elevation of both body
weight (Fig. 1A) and adipose weight (Fig. 1B) compared
to the chow fed mice, both sham-operated and adrenalec-
tomized. Although adrenalectomy initially caused a
greater loss of body weight in the diet-induced obese mice
(high fat-diet sham-operated mice lost 1.2 ± 0.5 g seven
days after surgery compared to diet adrenalectomized
mice who lost 2.9 ± 0.3 g; p < 0.05), by two weeks after the
surgery body weight in both groups had fully recovered
body weight to pre-surgery levels. In the sham-operated
mice, mass of food intake was significantly decreased in
mice on the high fat diet compared to the chow-fed mice
(Fig. 1C). Although the diet-induced obese mice con-
sumed more (calculated) calories than chow-fed mice
during the first week on the diet (during which the most
rapid weight gain was observed), by the fifth week they
were hypophagic both in terms of mass of food consumed
(g/day) and in calculated calories consumed (calories/
day) (the chow sham-operated mice consumed 16.1 ± 0.8
[calculated] cal/day compared to 12.9 ± 1.2 cal/day for the
diet sham-operated mice; p < 0.05).
Surprisingly, adrenalectomy had no effect on body weight
(Fig. 1A), adipose weight (Fig. 1B) or food intake (Fig. 1C)
for mice on either the chow diet or the high fat diet, five
weeks after initiation of the diet and three weeks after
adrenalectomy.
Effects of diet and adrenalectomy on serum hormones, glu-
cose tolerance and metabolic rate
Serum leptin was elevated in mice on the high-fat diet,
concordant with the development of obesity, but adrena-
lectomy had no effect on leptin levels (Table 1). Neither
insulin nor glucose was significantly influenced by either
diet or adrenalectomy (Table 1). The high fat diet had no
effect on serum corticosterone, but as expected adrenalec-
tomy reduced serum corticosterone by over 70% in mice
on both diets (Table 1). While this effect was significant,
consistent with previous studies [6], adrenalectomy did
not eliminate detectable corticosterone completely.
Glucose tolerance was strikingly impaired after only one
week on the high fat diet (Fig. 2; p < 0.0001). Adrenalec-
tomy slightly but significantly improved glucose tolerance
on the high fat diet (Fig. 2; p < 0.05). Total heat produc-
tion (not normalized to body weight) was significantly
elevated by the high fat diet (Fig. 3A; p < 0.0001) and
adrenalectomy led to a slight but statistical further
increase in heat production in the diet-induced obese
mice (Fib. 3B; p < 0.002). VO2 (oxygen consumption nor-
malized to body weight) was reduced in mice on the high
fat diet (Fig. 4A; p < 0.0001) and as with total heat produc-
tion adrenalectomy slightly but statistically increased VO2
in the diet-induced obese mice group (Fig. 4B; p < 0.05).
Therefore adrenalectomy led to a slight but statistical
increase in metabolic rate as well as glucose tolerance in
the diet-induced mice.BMC Physiology 2003, 3 http://www.biomedcentral.com/1472-6793/3/4
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Effects of diet and adrenalectomy on pituitary POMC 
mRNA
Although diet did not influence pituitary POMC mRNA,
adrenalectomy increased pituitary POMC expression in
mice on both diets (Table 1). Together with the reduction
in serum corticosterone, this induction of pituitary POMC
indicates that the adrenalectomy produced a physiologi-
cally significant reduction in corticosterone tone.
Effects of diet and adrenalectomy on hypothalamic 
POMC mRNA
The high-fat diet led to a slight but significant increase in
hypothalamic POMC mRNA in sham-operated mice (Fig-
ure 5A). Adrenalectomy produced a non-significant trend
toward an increase in hypothalamic POMC mRNA in
sham-operated mice, but a 5-fold induction of POMC
mRNA in mice on the high-fat diet (Fig. 5A). The high-fat
diet did not significantly influence hypothalamic AGRP in
this study, but surprisingly adrenalectomy slightly stimu-
lated hypothalamic AGPR mRNA levels (Fig. 5B).
Discussion
The high fat diet used in this study led to the development
of obesity over the course of five weeks as expected (Fig.
1A). As observed in leptin-deficient ob/ob mice, adrenalec-
tomy in diet-induced obese mice led to a striking increase
in hypothalamic POMC mRNA (Fig. 5A). This elevation
in hypothalamic POMC with only a very modest increase
in the antagonist AGRP mRNA (Fig. 5B) would be
expected to lead to significant amelioration of obese phe-
notypes, consistent with effects of adrenalectomy on other
forms of obesity [3–7]. Indeed adrenalectomy initially led
to a greater loss of body weight after surgery in the diet-
induced obese mice (results in text above). Surprisingly,
however, adrenalectomized mice regained all the weight
lost after surgery (Fig. 1A), and adrenalectomy also failed
to reduce food intake, adipose weight, or plasma leptin in
the obese mice.
As has been observed in other models of obesity due to a
high-fat diet, the diet-induced obese mice also became
hypophagic compared to the chow fed mice and com-
pared to the hyperphagia exhibited by mice in the first two
weeks on a high fat diet [28] (Fig. 1C). The hypophagia of
diet-induced obesity may be related to the modestly ele-
vated hypothalamic POMC, whose product alpha-MSH is
a known anorexic agent [20,29]. In turn, the induction of
hypothalamic POMC by the high-fat diet might have been
due in part to the elevation of leptin in diet-induced obese
mice (Table 1). The further elevation in POMC expression
observed after adrenalectomy of the obese mice could
plausibly be due to elevated leptin combined with
decreased glucocorticoids, since glucocorticoids may
antagonize the effects leptin [30].
Figure 1
Effect of high fat diet and adrenalectomy on body 
weight, adipose weight and food intake. High fat diet 
increased both (A) body weight (g) and (B) epididymal white 
adipose weight (g); adrenalectomy did not significantly affect 
either parameter. High fat diet also decreased calculated daily 
caloric intake (calories/day) (C), and this was also not signifi-
cantly influenced by adrenalectomy. Data are expressed as 
mean ± SEM. Groups with different letters are statistically 
different (p < 0.05) by ANOVA followed by Tukey-Kramer 
post hoc tests.
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Tolerance to a glucose load was also impaired in mice
after one week on the high-fat diet, suggesting the devel-
opment of insulin resistance (Fig. 2). However, neither
basal blood glucose nor serum insulin levels were elevated
by the high fat diet at this time point (Table 1). We have
observed in other studies that basal hyperinsulinemia is
not detected until mice have been on the high-fat diet for
at least two months (unpublished observations). Adrena-
lectomy led to only minor improvement in impaired glu-
cose tolerance (Fig. 2) and it did not affect blood glucose
or serum insulin levels (Table 1).
The key observation concerning food intake was that
adrenalectomy did not significantly influence food intake
on either diet. Mice on the high-fat diet ate less than the
mice on the chow diet, both in terms of mass consumed
and, surprisingly, in terms of total calculated caloric
intake (Fig. 1C). Since caloric intake was calculated with-
out normalization to body weight, for purposes of analyz-
ing metabolic economy the most valid comparison of
total caloric intake is to total caloric expenditure (total
heat production) without normalization to body weight,
as shown in Figure 3. Although the effect was small, the
increase on the high-fat diet in total heat production
without normalization to body weight was significant
(statistical reliability derived in part from the many
repeated measures, once every five minutes for 18 hours,
that measuring metabolic rate entails). Similarly, the very
small further increase in metabolic rate after adrenalec-
tomy was significant. When metabolic rate was normal-
ized to body weight, expressed as V02 (Figure 4A), the
effect of diet was to reduce this parameter, and adrenalec-
tomy increased very slightly but significantly caused this
measure of metabolic rate, normalized for body mass
(Figure 4B). The effect of diet on normalized metabolic
rate may be construed as suggesting that the failure of
metabolic rate to scale proportionally to the increase in
body weight on the high fat diet may have contributed to
the maintenance of the obese state, especially since the
calculated caloric intake on the high fat diet was less than
on the chow fat diet.
The key conclusion to be drawn from the metabolic rate
and food intake data is that effect of adrenalectomy on
metabolic rate was marginal, and there was no effect of
adrenalectomy on food intake, consistent with the lack of
effect of adrenalectomy on other obese phenotypes. Nev-
ertheless, with respect to the mechanism of diet-induced
obesity, the present data seem to indicate that the diet-
induced obese mice maintained their obesity despite
apparently decreased caloric intake and increased caloric
expenditure. Several explanations might account for this
anomalous result. First, caloric intake is calculated from
the caloric density as empirically measured and reported
by the manufacturers of the diets; it remains possible that
due to differences in these measurements, the true meta-
bolically available calories may differ from these empiri-
cally measured calories. If so, it remains possible that the
high-fat diet may actually include relatively more meta-
bolically available calories than the chow diet, and thus
that the mice on the high-fat diet in reality consumed
more metabolically available calories than reflected by
simple calculation of empirically determined caloric den-
sity. It is also possible that calories were absorbed more
efficiently on the high-fat diet. In any case, none of these
considerations compromise the basic observation that
adrenalectomy failed to reverse diet-induced obesity.
Since adrenalectomy only reduced plasma corticosterone
by about 70% in the obese mice, rather than completely
eliminating the steroid from circulation, it remains possi-
ble that even further reduction of corticosterone would
produce an effect on diet-induced obese phenotypes. On
the other hand, using the same adrenalectomy protocol
that produced a similar reduction, but not elimination, of
plasma corticosterone levels, we observed a remarkable
reversal of obese phenotypes in leptin-deficient ob/ob mice
[6]. Furthermore, the reduction of corticosterone by
adrenalectomy in the present study was sufficient to pro-
duce elevation of pituitary POMC mRNA (as well as
hypothalamic POMC mRNA), demonstrating that the
reduced levels were clearly producing physiological
effects. Consistent with these results, high fat diet attenu-
Table 1: Effect of high fat diet and adrenalectomy on serum hormones and pituitary POMC mRNA.
Group n Glucose (mg/dl) Insulin (ng/ml) Corticosterone 
(ng/ml)
Leptin (ng/ml) Pituitary POMC (%)
Chow/Sham 8 135 ± 7 1.7 ± 0.3 86 ± 14 1.8 ± 0.5 100 ± 38.7
Chow/ADX 10 148 ± 5 1.4 ± 0.3 11 ± 5.3* 1.6 ± 0.2 228 ± 36*
Diet/Sham 8 127 ± 13 1.9 ± 0.5 117 ± 23 11 ± 2.5* 154 ± 40
Diet/ADX 11 144 ± 6 1.6 ± 0.2 31 ± 7.0† 8.0 ± 1.5* 329 ± 50†
Effect of high fat diet and adrenalectomy on blood glucose (mg/dl), serum insulin (ng/ml), corticosterone (ng/ml), leptin peptide (ng/ml), and pituitary 
POMC mRNA (% chow sham-operated). Data are expressed as mean ± SEM. Groups with different symbols are statistically different (p < 0.05) by 
ANOVA followed by Tukey-Kramer post hoc test.BMC Physiology 2003, 3 http://www.biomedcentral.com/1472-6793/3/4
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ates the effect of adrenalectomy to reverse obese pheno-
types in ob/ob mice [31].
Conclusions
Diet-induced obesity led to significant increases in body
weight and adiposity and to the development of glucose
intolerance. Adrenalectomy reverses obese phenotypes
including melanocortin tone in mice models of obesity in
which plasma glucocorticoid levels are elevated. Consist-
ent with results in ob/ob mice, adrenalectomy did stimu-
late hypothalamic POMC mRNA associated with
marginal improvements in glucose tolerance and
metabolic rate in mice made obese by the high-fat diet.
However, these responses to adrenalectomy failed to
reduce food intake, body weight, adiposity, or leptin in
mice made obese by the high-fat diet, in which the obsese
state was not associated with elevated glucocorticoid lev-
els. Thus neither adrenalectomy nor remarkable enhance-
ment of hypothalamic POMC mRNA produced
significant attenuation of the diet-induced obese pheno-
type. In contrast to other models of obesity, however, diet-
induced obesity was not associated with either elevated
glucocorticoid levels or reduced hypothalamic POMC
mRNA. These data raise the possibility that potential anti-
obesity drugs based on reducing glucocorticoid tone or
elevating melanocortin tone may have limited efficacy in
treating forms of obesity in which those systems are not
perturbed.
Figure 2
Effect of high fat diet and adrenalectomy on glucose 
tolerance. High fat diet led to impairments in glucose toler-
ance, which was slightly improved by adrenalectomy. *Sham-
operated mice on a high fat diet exhibited significant impair-
ments in glucose tolerance compared to chow sham-oper-
ated mice by ANOVA (p < 0.0001). †Adrenalectomized mice 
on a high-fat diet showed statistical improvements in glucose 
tolerance compared to diet sham-operated mice by ANOVA 
(p < 0.05). Data are expressed as mean ± SEM. Black 
square=chow sham-operated mice; white square=chow 
adrenalectomized mice; black circle=diet sham-operated 
mice; white circle=diet adrenalectomized mice.
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Effect of high fat diet and adrenalectomy on heat 
production. Total heat production reflects metabolic rate 
without normalization to body weight. (A) High-fat diet 
increased heat production in the sham-operated mice (chow 
sham-operated vs. diet sham-operated) statistically by 
ANOVA (p < 0.0001). (B) Adrenalectomy increased heat 
production further in diet-induced obese mice (diet sham-
operated vs. diet adrenalectomized) by ANOVA (p < 0.002). 
Data are plotted as an average, within each group, of every 
five-minute interval between 18:00 hours and 12:00 hours.
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Methods
Animals
The appropriate Institutional Animal Review Board had
approved all studies.
Male C57Bl/6J mice were obtained at 8 months of age
from The Jackson Laboratory (Bar Harbor, ME) and were
individually housed with free access to feed and water
under 12:12 h light-dark cycle (lights on at 07:00 h). This
age was chosen because body weight is stable at this age,
facilitating interpretation of the expected opposing effects
of diet and adrenalectomy. The C57Bl/6J strain was cho-
sen for susceptibility to obesity on a high fat diet [22,32–
34]. Mice were placed on either a high fat diet (diet
#D12492; Research Diets, New Brunswick, NJ) or regular
rodent chow diet (diet #5053; Purina Mills, Richmond,
IN) for a total of five weeks during which time both body
weight and food intake was monitored daily. Cages were
changed daily and a sieve was used to measure spilt food.
The high fat diet (5.2 kcal/g) consisted of 20 kcal% pro-
tein, 20 kcal% carbohydrate and 60 kcal% fat, while the
standard rodent chow diet (3.08 kcal/g) consisted of 23
Figure 4
Effect of high fat diet and adrenalectomy on oxygen 
consumption. Oxygen consumption (VO2 ) reflects meta-
bolic rate normalized to body weight. (A) High-fat diet 
decreased VO2 in the sham-operated mice (chow sham-
operated vs. diet sham-operated) statistically by ANOVA (p 
< 0.0001). (B) Adrenalectomy increased VO2 in diet-induced 
obese mice (diet sham-operated vs. diet adrenalectomized) 
by ANOVA (p < 0.05). Data are plotted as an average, within 
each group, of every five-minute interval between 18:00 
hours and 12:00 hours.
Figure 5
Effect of high fat diet and adrenalectomy on hypotha-
lamic POMC and AGRP mRNA. Hypothalamic (A) 
POMC and (B) AGRP mRNA as measured by Northern blot 
analysis. Data are expressed as mean percentage of chow 
sham-operated mice ± SEM. Groups with different letters are 
statistically different (p < 0.05) by ANOVA followed by 
Tukey-Kramer post hoc tests.
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kcal% protein, 64 kcal% carbohydrate and 11 kcal% fat.
More specifically, the composition of the high fat diet was
(per kg): casein, 80 mesh (200 g), L-cystine (3 g), malto-
dextrin 10 (125 g), sucrose (68.8 g), cellulose, BW200 (50
g), soybean oil (25 g), lard (245 g), mineral mix (10 g),
dicalcium phosphate (13 g), calcium carbonate (5.5 g),
potassium citrate (16.5 g), vitamin mix (10 g), choline
bitartrate (2 g) and FD&C Blue Dye #1 (0.05 g).
After one week on their respective diets, tolerance to a glu-
cose load was tested by injection of a glucose solution (2
mg/g body weight, i.p.) monitored for three hours after
injection. Previous to the glucose tolerance test, food was
removed from the cages for five hours from 09:00 to 14:00
hours. After two weeks on the high-fat diet, mice from
both chow and high-fat diets were either bilaterally
adrenalectomized or sham-operated as previously
described [6]. All mice were then given one injection of
dexamethasone (45 mg/kg body weight i.p.) to facilitate
recovery from the surgery. The drinking water was
replaced with normal saline (0.9% NaCl) to compensate
for the loss of mineralocorticoids. Two weeks after the
surgery when all mice had recovered body weight lost due
to the stress from the surgery, another glucose tolerance
test was performed, and after another week, all the mice
were placed into metabolic cages in groups of eight in a
balanced design. Metabolic rate was monitored continu-
ously by indirect calorimetry for 18 hours as previously
described [35,36]. Food and water were freely available in
the metabolic cages. Briefly, air from each cage was sam-
pled every five minutes and oxygen and carbon dioxide
concentrations from each sample were measured inde-
pendently. From the change in oxygen, VO2  was
calculated as oxygen consumption per hour normalized
to body weight (ml/kg/hour). Heat production was then
calculated using the following formula: Heat (cal/hour) =
((4.33+0.67 × (VCO2 /VO2 )) × VO2 × (Body weight) ×
60). Therefore, the parameter VO2 is normalized to body
weight, whereas heat production is not normalized to
body weight and so reflects total energy expenditure.
The mice were sacrificed toward the end of the light
period at the end of the day in the metabolic cages
(between 17:00 and 19:00 h) by decapitation after a brief
exposure to carbon dioxide and trunk blood was col-
lected; we have verified in pilot studies that this method
of sacrifice does not increase plasma corticosterone above
levels observed without carbon dioxide exposure. Brains
for Northern blot analysis were quickly removed and the
hypothalamus was dissected out, frozen on dry ice and
stored at -70°C until use as described previously
[Makimura, 2000 #5346; [Mizuno, 1999 #5302]. In addi-
tion, the anterior lobe of the pituitary was also removed
and frozen on dry ice and stored at -70°C until use. Epidi-
dymal white adipose tissue was also removed, weighed
and frozen on dry ice and stored at -70°C until use. The
four groups that resulted from this experimental design
was as follows: chow sham-operated (n=8), chow adrena-
lectomized (n=10), diet sham-operated (n=8), and diet
adrenalectomized (n=11). Successful adrenalectomy was
verified by visual inspection at the time of sacrifice, as well
as by the induction of pituitary proopiomelanocortin
(POMC) mRNA levels and the reduction in serum corti-
costerone levels.
Blood chemistry
Blood glucose levels were measured by a Lifescan One-
Touch II glucose meter (Johnson & Johnson, Mountain
View, CA). Serum insulin and leptin peptide levels were
assayed by ELISA with commercial kits (CRYSTAL CHEM
INC., Chicago, IL) and serum corticosterone was assayed
by RIA with a commercial kit (ICN Pharmaceuticals Inc.,
Costa Mesa Ca).
Northern blot analysis
Hypothalamic proopiomelanocortin (POMC) and
agouti-related peptide (AGRP) mRNA and pituitary
POMC mRNA were measured by Northern blot analysis as
previously described [6]. Briefly, total RNA was extracted
in TRIzol (GIBCO BRL, Gaithersburg, MD) and three
micrograms of total RNA from hypothalamus, estimated
by spectrophotometer and verified by gel electrophoresis,
was subjected to Northern blot analysis to measure
POMC and AGRP mRNA. Three micrograms of total RNA
from anterior pituitary was used to measure pituitary
POMC mRNA. Total RNA was denatured in a mixture of
glyoxal and dimethyl sulfoxide for 1 hr at 50°C and elec-
trophoresed for 60 minutes on a 10 mM sodium
phosphate agarose gel. The RNA was transferred to an
Immobilon membrane over night in 20 × standard saline
citrate (SSC) by capillary action. The membrane was sub-
sequently baked for several hours at 80°C and cross-
linked with UV light at 33000 uJ/cm2 energy. The mem-
branes were prehybridized in a commercial Ultrahyb
buffer (Ambion, Inc., Austin, TX) for 1 to 2 hours at 65°C.
Hybridization was carried out in the same buffer with a
single stranded internally labeled 32 P probe over night at
42°C. The membranes were washed in 1 × SSC/0.1% SDS
for 15 minutes at room temperature twice followed by
two more washes with 0.1 × SSC/0.1%SDS for 15 minutes
at room temperature. Finally, the membrane was washed
in 0.1 × SSC/0.1%SDS for 3 hours at 42°C, and exposed
to a phosphoimager screen over night. The Northern blots
were probed using single-stranded internally labeled DNA
probes as described previously [6]. Membranes were re-
probed and hybridized with 32 P-labeled probe encoding
18S ribosomal RNA and all signals were normalized to
this 18S signal upon quantification. The total integrated
densities of hybridization signals were determined byBMC Physiology 2003, 3 http://www.biomedcentral.com/1472-6793/3/4
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phosphoimager (STORM 860, Molecular Dynamics, Sun-
nyvale, CA).
Statistical analysis
Statistical analysis was performed by a two-way analysis of
variance (ANOVA) followed, when indicated by appropri-
ate p-values (p < 0.05), by Tukey-Kramer post-hoc test,
using the JMP statistical package implemented on the
Macintosh operating system. For the glucose tolerance
tests and metabolic rate measurements, a two-way
ANOVA (treatment × time) was performed using the JMP
statistical package.
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